Esophageal Cancer Drugs Market is expanding rapidly with Innovent Biologics, Inc. and Eli Lilly and Company jointly releasing the results of seven clinical studies of TYVYT (sintilimab injection) covering indications including esophageal cancer, gastric cancer, and lung cancer
Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility